Powder: -20°C for 3 years | In solvent: -80°C for 1 year
1. 3-Dehydrotrametenolic acid can be a potential anticancer agent against H-ras transformed tumor. 2. Dehydrotrametenolic acid is a promising candidate for a new type of insulin-sensitizing drug.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 77.00 | |
5 mg | In stock | $ 193.00 | |
10 mg | In stock | $ 328.00 | |
25 mg | In stock | $ 553.00 | |
50 mg | In stock | $ 789.00 | |
100 mg | In stock | $ 1,070.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 229.00 |
Description | 1. 3-Dehydrotrametenolic acid can be a potential anticancer agent against H-ras transformed tumor. 2. Dehydrotrametenolic acid is a promising candidate for a new type of insulin-sensitizing drug. |
Source |
Synonyms | Dehydrotrametenolic acid |
Molecular Weight | 454.68 |
Formula | C30H46O3 |
CAS No. | 29220-16-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Chloroform, Dichloromethane, Ethyl Acetate, Acetone, etc.: Soluble
DMSO: 12 mg/ml (26.39 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
3-Dehydrotrametenolic acid 29220-16-4 Apoptosis Metabolism Others Dehydrogenase 3Dehydrotrametenolic acid inhibit Lactate Dehydrogenase 3 Dehydrotrametenolic acid Dehydrotrametenolic acid LDH Inhibitor inhibitor